<ѻý>Zytiga May Up Mortality Risk in Prostate Cancer Patients With CVDѻý> Increased hospitalizations seen among all abiraterone-treated patients Feb 27, 2019
<ѻý>One-Time FIT Adequately Detects CRC but Not Advanced Adenomasѻý> Accuracy depends on varying test thresholds for positive result Feb 25, 2019
<ѻý>Significant Decline in Precancerous Cervical Lesions in U.S.ѻý> Proportion of lesions with HPV16/18 fall across age, ethnic groups Feb 21, 2019
<ѻý>No Survival Bump Yet with Tivozanib for RCCѻý> Selected studies on kidney cancer from the Genitourinary Cancers Symposium Feb 18, 2019
<ѻý>'Encouraging' Early Data with Keytruda in High-Risk Bladder Caѻý> Will responses in non-muscle-invasive, BCG-unresponsive disease prove durable? Feb 17, 2019
<ѻý>Bladder Ca Treatment Enters 'Post-Checkpoint' Eraѻý> Early trials show responses with antibody-drug conjugates Feb 16, 2019
<ѻý>Doubling Down on Antiandrogens Improves PFS in Metastatic Prostate Caѻý> But lack of OS data for enzalutamide-ADT may hold it back Feb 15, 2019 video
<ѻý>Immunotherapy Lurches Forward in Prostate Cancerѻý> Combination trials in mCRPC yield responses in immunologically "cold" tumor Feb 15, 2019
<ѻý>Surveillance of Low-Risk Prostate Cancer Tripledѻý> Radical prostatectomy gained some ground for high-risk disease Feb 12, 2019 video
<ѻý>Radiological Agent Shows Promise in Heavily Treated mCRPCѻý> PSA decline of 50% or greater in two-thirds of patients Feb 12, 2019 video
<ѻý>Better Survival for African-Americans With mCRPCѻý> Significant improvement vs whites with androgen-directed agents Feb 11, 2019 video
<ѻý>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxabanѻý> Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial Feb 08, 2019
<ѻý>Fewer Colectomy Procedures Performed Among Ulcerative Colitis Patientsѻý> Surveillance efforts may lead to more treatment options for this patient group Feb 08, 2019
<ѻý>Colonoscopy Misses More Adenomas Than Thoughtѻý> Forget 'one and done' -- adenomas per positive colonoscopy better measure of quality, researchers say Feb 08, 2019
<ѻý>Rats, My PSA Went Up. Do I Need Another Bleeping Biopsy?ѻý> "Active surveillance" doesn't have to mean invasive testing for every biomarker blip Jan 29, 2019
<ѻý>Rapid Heart Rate Tied to Higher Mortality in Cancer Patientsѻý> Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<ѻý>Genetic Profiling Disappoints for CUP Survivalѻý> But testing in cancer of unknown primary site did help with prognosis Jan 24, 2019
<ѻý>High Response Rate in HER2+ Esophagogastric Cancerѻý> Summary findings from the Gastrointestinal Cancers Symposium Jan 23, 2019
<ѻý>Death Risk Rises With No Colonoscopy After Stage I CRCѻý> Three-fold increase, but is colonoscopy the driver? Jan 22, 2019
<ѻý>Mixed Results with Immune Tx in Advanced, Refractory Colon Caѻý> Overall survival gains were modest to none in different stages of CRC Jan 20, 2019
<ѻý>Metastatic Gastric Ca Treatments Show Mixed Resultsѻý> FTD/TPI effective, but mFOLFOX plus biologic didn't improve survival Jan 20, 2019
<ѻý>'Incredibly Impressive' Activity in Biliary Ca with Combo Txѻý> Responses in about 40% of patients with BRAF/MEK inhibitor pairing Jan 20, 2019
<ѻý>Will Biomarkers Eventually Replace Physicians?ѻý> Milton Packer imagines the end of nonprocedural medicine as we know it Jan 16, 2019
<ѻý>Surgery/HIPEC Safer Than Other High-Risk Cancer Proceduresѻý> Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
<ѻý>Active Smokers Far More Likely to Fail on Chemo for Bladder Caѻý> Higher rates of disease recurrence seen as well Jan 10, 2019
<ѻý>V600K-Mutant Melanoma May Merit First-Line Immunotherapyѻý> Higher mutational load is less responsive to targeted therapy with BRAF/MEK inhibition Jan 10, 2019
<ѻý>Less Invasive Surgery Wins in Esophageal Cancerѻý> Large reduction in major complications at 1 month out Jan 09, 2019
<ѻý>Does Johnson's Baby Powder Cause Cancer?ѻý> Milton Packer says the $4.69-billion verdict is about anger, not medicine Jan 09, 2019
<ѻý>Trump Proposes Overhaul of Part B Drugsѻý> Plan hinges on benchmarking U.S. prices to those abroad Jan 04, 2019
<ѻý>MSI Status in Prostate Ca Could ID Immunotherapy Respondersѻý> But not all MSI-high patients saw benefit with checkpoint inhibitors Dec 27, 2018
<ѻý>Cancer Treatment and Arthritis: A Growing Complaintѻý> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻý>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancersѻý> Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<ѻý>Kidney Stones Tied to Renal Carcinomaѻý> But more research is needed to unravel mechanisms behind the relationships, study authors say Dec 20, 2018
<ѻý>Sorafenib 'New Standard of Care' for Patients With Desmoid Tumorsѻý> Toxicity led to treatment discontinuation in 20% of patients Dec 19, 2018
<ѻý>Higher Risk of Shingles Seen in Patients With Certain Cancersѻý> Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
<ѻý>Immunotherapy Combo Flops in Metastatic NSCLCѻý> Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<ѻý>Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancerѻý> Breast-conservation options were associated with better sexual, psychosocial outcomes Dec 07, 2018
<ѻý>Visual Guide to AVERT's VTE Prevention in Cancerѻý> Apixaban effective against important chemotherapy side effect Dec 07, 2018
<ѻý>ASH Poster Rounds: Adding BTK Inhibitor Safe in First-Line MCLѻý> Plus: Lenalidomide upfront in PTCL; skipping RT in primary mediastinal B-cell lymphoma Dec 07, 2018